Market closedNon-fractional

Xtant Medical/XTNT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Xtant Medical

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Ticker

XTNT

Sector

Healthcare

Trading on

AMEX

Industry

Health Care Equipment and Supplies

Headquarters

Belgrade, United States

Employees

211

Xtant Medical Metrics

BasicAdvanced
$85M
Market cap
-
P/E ratio
-$0.01
EPS
0.33
Beta
-
Dividend rate
$85M
0.33
2.34
0.915
36.848
60.315
-3.77%
-9.58%
-4.13%
0.805
1.79
2.78
-5.506
60.81%
-84.08%
25.59%
-49.25%

What the Analysts think about Xtant Medical

Analyst Ratings

Majority rating from 2 analysts.
Buy

Xtant Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-15.82% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$28M
-1.07%
Net income
-$4.4M
2.33%
Profit margin
-15.82%
3.40%

Xtant Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 100.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.02
$0.07
-$0.03
-$0.03
-
Expected
-$0.02
-$0.02
-$0.03
-$0.02
-$0.02
Surprise
0.00%
-450.00%
20.00%
100.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Xtant Medical stock?

Xtant Medical (XTNT) has a market cap of $85M as of July 06, 2024.

What is the P/E ratio for Xtant Medical stock?

The price to earnings (P/E) ratio for Xtant Medical (XTNT) stock is 0 as of July 06, 2024.

Does Xtant Medical stock pay dividends?

No, Xtant Medical (XTNT) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Xtant Medical dividend payment date?

Xtant Medical (XTNT) stock does not pay dividends to its shareholders.

What is the beta indicator for Xtant Medical?

Xtant Medical (XTNT) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Xtant Medical stock

Buy or sell Xtant Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing